...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Private placement one million plus units for US$2, half wt exercisable at US3, good for 3 years

Hi Dutch I never received a notice.Where did you see it

Share
New Message
Please login to post a reply